ScholarMate
English简体中文繁體中文
Customer service: 400-1616-289
Sign inSign up
Journal article

Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment

Yin, Zi*; Ma, Tingting; Chen, Sheng; Yu, Min*广东省人民医院; 南方医科大学; 中山大学
Cancer Biomarkers2023DOI: 10.3233/CBM-210300
1Cited by8Reads
CiteSave
Share

Abstract

BACKGROUD: Hepatocellular carcinoma (HCC) is characterized by occult onset, rapid progression and poor prognosis. CXC chemokines play an important role in tumor microenvironment and development. OBJECTIVE: The potential mechanistic values of CXC chemokines as clinical biomarkers and therapeutic targets in HCC have not been fully clarified. METHODS: ONCOMINE, UALCAN, GEPIA, cBioPortal, SurvExpress, MethSurv, SurvivalMeth, String, GeneMANIA, DAVID, Metascape, TRRUST, LinkedOmics, and Timer were applied in this study. RESULTS: The transcriptional levels of CXCL9/16/17 in HCC tissues were significantly elevated while CXCL1/2/5/6/7/12/14 were significantly reduced. Significant correlation was found between the expression of CXC3/5 and the pathological stage of HCC patients. High level of CXCL4 was associated with a longer disease-free survival. For overall survival, lower expressions of CXCL1/3/5/8 and higher expressions of CXCL2 were associated with a better outcome. In addition, the prognostic values of CXC chemokines signature in HCC were explored in four independent cohorts, the high-risk group displayed unfavorable survival outcome compared with the low-risk group. And for the prognostic value of the DNA methylation of CXC chemokines, we identified the CpGs which were significantly associated with prognosis in HCC patients. DNA methylation signature analysis also showed a statistically significant association between the high- and low-risk groups. For potential mechanism, the neighbor gene networks, interaction analyses, functional enrichment analyses of CC chemokine receptors in HCC were performed, the transcription factor targets, kinase targets, and miRNA targets of CXC chemokines were also identified in HCC. We also found significant correlations among CXC chemokines expression and the infiltration of immune cells, the tumor infiltration levels among HCC with different somatic copy number alterations of these chemokine receptors were also assessed. Moreover, the Cox proportional hazard model showed that CCR2/6/8/12, B cell, macrophage and dendritic cell were significantly related to the clinical outcome of HCC patients. CONCLUSION: CXC chemokines might serve as therapeutic targets and prognostic biomarkers in HCC.

Disciplines and keywords

Keywords
CXC chemokinesHCCprognostic biomarkertherapeutic target
Related
Loading…
  • Identification of prognostic immune cells and potential immune-related markers in hepatocellular carcinoma
    Mai, Jialuo; Hua, Xuefeng; Bian, Zhen-Hua; Xia, Yu; Zhao, Zhi-Bin; Lu, Minqiang*Translational Cancer Research, 2022, 11(7): 2262-+.Cited by 2
  • Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma
    Yu, Hongjun; Wang, Chaoqun; Ke, Shanjia; Bai, Miaoyu; Xu, Yanan; Lu, Shounan; Feng, Zhigang; Qian, Baolin; Xu, Yue; Zhou, Menghua; Li, Zihao; Yin, Bing; Li, Xinglong; Hua, Yongliang; Zhou, Yongzhi; Pan, Shangha; Fu, Yao*; Ma, Yong*Frontiers in Immunology, 2022, 13: 892750.Cited by 4
  • CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
    Zou, Yiping; Ruan, Shiye; Jin, Liang; Chen, Zhihong; Han, Hongwei; Zhang, Yuanpeng; Jian, Zhixiang; Lin, Ye; Shi, Ning*; Jin, Haosheng*MEDICAL SCIENCE MONITOR, 2020, 26: e925289.Cited by 60
View all →

Publication info

Publication status
Published
Journal
Cancer Biomarkers
Publication date
2023
Volume / issue
Vol. 36, Issue 3
Pages
231-250
DOI
10.3233/CBM-210300
Language
ENGLISH
Output indexing
SCIE
Funding acknowledgment
Natural Science Foundation of Guangdong [2021A1515012234]; Science and Technology Program of Guangzhou [201904010043]; National Key Clinical Specialty Construction Project [2021-2024, 2022YW030009]

Authors

  • Y

    Yin, Zi (Corresponding) (First author)

    2 · guangdong prov peoples hosp · southern med univ

  • M

    Ma, Tingting

    sun yat sen univ

View all 4 authorsShow fewer authors
  • C

    Chen, Sheng

    2 · guangdong prov peoples hosp · southern med univ

  • Y

    Yu, Min (Corresponding)

    2 · guangdong prov peoples hosp · southern med univ

Sign in for more features

  • Save this paper in My collections
  • Claim your outputs and generate promotion materials
  • Follow authors for new outputs
  • Join groups and collaborate
Sign up / Sign in

Products

  • ScholarMate
  • InnoCity
  • IRISaaS

Support

  • Help Center
  • Privacy Policy
  • Terms of Service

Contact

Online support: []
Customer service: 400-1616-289
Email: support@scholarmate.com

Follow or download ScholarMate

WeChat QR code
WeChat official account
App download QR code
Download the app
OutputsResearchersResearch institutionsResearch newsIRISaaS

©2026 深圳市科研之友网络服务有限公司

Public security registration badge粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417